Juvenile amyopathic dermatomyositis

British Journal of Dermatology

Volumn 136, Issue 3, 1997, Pages 431-433

  Schmid, M Hess ^a   Trueb R M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE;

ADOLESCENT; ARTICLE; CASE REPORT; DERMATOMYOSITIS; ELECTROMYOGRAM; FEMALE; HUMAN; PRIORITY JOURNAL;

EID: 8044257722     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb14961.x     Document Type: Article

References (22)

1. Trautmann C, Badawy Abdel-Naser M, Soehnchen R et al. Prämyopathische versus amyopathische Dermatomyositis. Hautarzt 1995; 46: 47-52.
2. Stonecipher MR, Jorizzo JC, White WL et al. Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: amyopathic dermatomyositis? J Am Acad Dermatol 1993; 28: 951-6.
3. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). J Am Acad Dermatol 1991; 24: 959-66.
4. Krain LS. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol 1975; 3: 241-5.
5. Pearson CM. Polymositis and dermatomyositis. In: Arthritis (and Allied Conditions) (McCarty DJ, ed.), 9th edn. Philadelphia: Lea & Febiger, 1977; 742-82.
6. Euwer RL and Sontheimer R. Amyopathic dermatomyositis: a review. J Invest Dermatol 1993; 100: 124-7S.
7. Braverman I. Connective tissue (rheumatic) diseases. In: Cutaneous Signs of Systemic Disease, 2nd edn. Philadelphia: W.B.Saunders, 1987: 300-10.
8. Euwer RL, Sontheimer RD. Dermatomyositis. In: Cutaneous Manifestations of Rheumatic Diseases (Sontheimer RD, Provost TT, eds), 1st edn. Baltimore: Williams and Wilkins, 1996; 73-114.
9. Stonecipher MR, Callen JP, Jorizzo JC. The red face: dermatomyositis. Clin Dermatol 1993; 11: 261-73.
10. Bohan A, Peter J, Bowman R, Pearson C. A computer assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255-86.
11. Woo TY, Callen J, Voorhees J et al. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 1984; 10: 592-9.
12. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993; 100: 116-23S.
13. Stonecipher MR, Jorizzo JC, Monu J et al. Dermatomyositis with normal muscle enzyme concentrations. Arch Dermatol 1994; 130: 1294-9.
14. Hernandez RJ, Sullivan DB, Chenevent TL, Keim DR. MR imaging in children with dermatomyositis: musculoskeletal findings and correlation with clinical and laboratory findings. Am J Radiol 1993; 161: 359-66.
15. Kaufman LD, Gruder BL, Berstman DR et al. Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheum Dis 1987: 46: 569-72.
16. Keim DR, Hernandez RJ, Sullivan DB. Serial magnetic resonance imaging in juvenile dermatomyositis. Arthritis Rheum 1991; 34: 1580-4.
17. Park JH, Olsen NJ, King LI et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995; 38: 68-77.
18. Cherin P, Herson S, Wechsler B et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 1991; 91: 162-8.
19. Lang BA, Laxer RM, Murphy G et al. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 1991; 91: 169-72.
20. Schmidt K, Westenberger-Treumann M, Stadier R. Hochdosierte intravenöse Gammaglobulin-Therapie bei juveniler Dermatomyositis. Hautarzt 1994; 45: 854-7.
21. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994; 94: 1729.
22. Quinti I, Sacco G, el Salman D et al. Infection with hepatitis C virus. Intravenous gammaglobulin may still infect patients (letter). Br Med J 1994; 308: 856.